Register for IPO Updates
US IPO Stats
IPO Industry Breakdown
Largest Global IPOs
Largest US IPOs
IPO News Archive
New Ways to Invest in IPOs - IPO ETFs
Week ahead: One of the most highly-anticipated IPOs of 2015
Analyst IPO Market Commentary
A still fragile US IPO market will look to continue to find its footing this week.
Companies have experienced significant pricing pressure in the last few weeks, with 11 out of the last 13 IPOs pricing below the range. Next week, a highly-anticipated premier luxury brand, a specialty packaging company, and two biotechs plan to go public. Three other companies are listed as day-to-day, carryovers from this past week.
While the IPO market remains choppy and is being dictated by severe price concessions, there is reason to think that conditions may start to improve. Aftermarket returns are now trending positive and the closely watched volatility index has fallen to 15, its lowest level since July 2015. Filing activity also picked up materially over the past week, with new entrants from four tech firms. October has now seen 24 IPO filings through mid-month, up from 11 for all of September, and trending to be the busiest October since 2013, when 30 companies filed.
The Prancing Horse goes public
In one of the most highly-anticipated IPOs of the year,
) expects to raise $859 million. Owned by Fiat since 1969, this Italian luxury sports car maker is being spun off to unlock the value of one of the world's most coveted brands. The company maintains the exclusivity of its brand through production limits, shipping only 7,255 cars last year, and months-long waitlists. With the population of high-net-worth individuals growing worldwide, the company aims to increase shipments to Asia, especially China.
Is this the total package?
Multi Packaging Solutions
) is a global print-based specialty packaging company that makes premium print cartons, inserts, labels and rigid packaging. It was acquired by Madison Dearborn in 2013 and merged with Carlyle-backed Chesapeake in 2014 in a transaction that more than doubled its size. The company is targeting 2- % organic growth, but it plans to supplement growth with $50-$100 million in annual acquisitions. Next week, the company hopes to raise $300 million with primary proceeds expected to help reduce its $1.2 billion debt load.
Biotechs for humans and dogs
) is a preclinical gene therapy biotech that selectively targets liver cells to deliver missing intact genes for rare diseases. The company submitted an IND in August 2015 for lead candidate DTX101 for hemophilia B, received Orphan Drug and Fast Track designations from the FDA, and plans to begin a Phase 1/2 trial by the end of 2015. It licenses its AAV vector gene delivery technology from REGENXBIO (
), which completed an IPO in September 2015. REGENXBIO popped 38% in its debut, but it now trades 14% below its offer price. Backed by Fidelity and OrbiMed, Dimension looks to raise $83 million in what continues to be a tough market for biotech companies.
), which is developing formulations of widely-used cancer drugs for humans and dogs, looks to raise $20 million in a US IPO. It amended its filing on September 15, targeting a mid-September IPO, only to push it back multiple times to this week. It already trades on Nasdaq Stockholm and the Frankfurt Stock Exchange.
Three companies are waiting for the opportune timing
Several companies are listed as day-to-day. This past week,
) decreased its range, then failed to price. The company, a fabless provider of flash memory chips for Internet of Things devices, hopes to raise $42 million.
American Farmland Company
), an internally managed REIT formed to acquire and lease a diversified portfolio of US farmland, did not price as scheduled. It expects to raise $114 million in its offering. The last day-to-day company, China-based
Sole Elite Group (
), is a profitable designer and producer of foam and rubber shoe soles used to manufacture sports shoes. It expects to raise $33 million in its IPO.
IPO Pipeline Update: Meaningful filings pick up
In the past week,
) postponed its $ 1.6 billion IPO, but indicated it may relaunch in the coming weeks.
Neiman Marcus Group
) announced that it would push its IPO date back to early 2016. One of the few remaining mega LBOs from the 2006-2007 buyout boom,
) has yet to set a date for an IPO that we estimate could raise up to $1.0 billion. A diverse group of companies filed this week too: two LBOs, Station Casinos (
; a spinoff,
); a high-profile unicorn,
); and an assortment of biotech companies, a medical technology company, and two other technology companies.
Renaissance Capital's IPO
- Week of
$48.00 - $52.00
UBS Investment Bank
BofA Merrill Lynch
Italian luxury sports car manufacturer being spun off from Fiat Chrysler.
Multi Packaging Solutions Int'l
New York, NY
$15.00 - $17.00
BofA Merrill Lynch
Global manufacturer of print-based packaging for consumer/health care products.
$14.00 - $16.00
Developing novel, liver-directed gene therapies for rare genetic disorders.
American Farmland Company
New York, NY
$8.50 - $10.50
Internally managed REIT with farmland in California, Illinois and Florida.
$7.00 - $7.00
Fabless provider of flash memory chips for Internet of Things devices.
$5.75 - $7.75
Joseph Gunnar & Co.
Rodman & Renshaw
Developing formulations of widely-used cancer drugs for humans and dogs.
IPO ETF manager Renaissance Capital
Find out why institutional investors rely on Renaissance Capital's
for these IPOs.
Follow us on Twitter (
) for IPO news as it happens and
register for our updates
on the IPO market.
IPO Market Snapshot
The Renaissance IPO Index has traded down 6.9% year-to-date, compared to -2.1% for the S&P 500. Renaissance Capital's
(NYSE: IPO) tracks the index, and
top ETF holdings
include Alibaba (
), Hilton Worldwide (
) and Twitter (
). The Renaissance International IPO Index has traded down 1% year-to-date, compared to -2.7% for the ACWX. Renaissance Capital’s International
(NYSE: IPOS) tracks the index, and
top ETF Holdings
include Recruit Holdings and Cheil Industries.
To find out if this is the best ETF for you, visit our
IPO Investing page
Keywords / Tickers:
ETF Express Award:
ETFExpress awards are based on a 'peer review system' whereby readers - including institutional and high net worth investors as well as managers and other industry professionals at fund administrators, brokers, custodians and advisers - are invited to elect a 'best in class' in a series of categories via an online survey. In each category, the firms with the most votes at the end of the voting period are subject to a final review by ETFExpress's Senior Editorial team.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.
As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund's average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees.
An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.
Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds.
Renaissance IPO Index® (IPOUSA)
is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios.
Renaissance International IPO Index® (IPOXUS)
is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges.
The S&P 500® Index (SPX) is a stock market index which includes 500 U.S. listed companies and seeks to capture approximately 80% coverage of available U.S. market capitalization.
Risk Disclosure: Investments in the
Renaissance IPO ETF, symbol "IPO"
Renaissance International IPO ETF, symbol "IPOS"
(the "ETFs"), and the
Global IPO Fund, symbol "IPOSX"
(the "Mutual Fund") are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the "Funds") invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.
Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit
. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Definitions: The Renaissance IPO Index® is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The S&P 500® Index is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE or Nasdaq.
The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.
Register for Updates
Renaissance Capital LLC is an SEC-registered investment adviser.
Renaissance Capital Investments, Inc. is a
-registered broker-dealer, and member of
© 2016 Renaissance Capital LLC. All rights reserved.